CADL CANDEL THERAPEUTICS INC

Ownership history in Point72 (DIFC) Ltd  ·  2 quarters on record

This page tracks every 13F SEC filing in which Point72 (DIFC) Ltd reported a position in CANDEL THERAPEUTICS INC (CADL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q2 REDUCED 146 -4,781 -97.0% 0.00% $740 $5.06
2024 Q2 INITIATED 4,927 0.00% $31K
% of Fund (quarterly)    CADL price (monthly, adj. close)
← Back to Point72 (DIFC) Ltd Holdings